Daniel M.
- Country
- Germany
- Department
- Klinik für Pneumologie
Research Overview
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Phase 3 Study of Pumitamig Versus Pembrolizumab in Previously Untreated Advanced Non-Small Cell Lung Cancer with PD-L1 ≥50%
Data & Insights
Has run more than one trial at 254 of 483 partner sites.
Specializations
Lung Cancer Specialization
The investigator focuses on advanced therapeutic approaches for various forms of lung cancer, particularly non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Their research encompasses both early-stage and metastatic disease states.
- Advanced NSCLC Treatment
- Metastatic Disease Management
- Stage III Unresectable NSCLC
A significant portion of work involves evaluating innovative combination therapies and targeted treatments for specific genetic mutations.
Molecular Targeted Therapies
Specializes in precision medicine approaches targeting specific genetic alterations in lung cancer, including KRAS G12C mutations, EGFR mutations, and ALK-positive disease.
- Targeted Treatment Development
- Biomarker Analysis
- Resistance Mechanism Studies
Explores novel therapeutic combinations to overcome treatment resistance and improve patient outcomes.
Immunotherapy Research
Conducts research on immunotherapeutic approaches, particularly focusing on checkpoint inhibitors and their combinations with conventional treatments for thoracic malignancies.
- Combination Immunotherapy
- First-line Treatment Strategies
- Maintenance Therapy Development
Investigates novel immunotherapy combinations including dual checkpoint blockade strategies.
Thoracic Oncology
Extends expertise to other thoracic malignancies, including pleural mesothelioma and complex lung cancer presentations with central nervous system involvement.
- Multimodal Treatment Approaches
- CNS Metastases Management
- Rare Thoracic Cancers
Focuses on developing comprehensive treatment strategies for challenging thoracic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.